nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—ALB—focal segmental glomerulosclerosis	0.567	1	CbGaD
Celecoxib—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.401	CbGbCtD
Celecoxib—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0179	0.366	CbGbCtD
Celecoxib—Fibroadenosis of breast—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0627	CcSEcCtD
Celecoxib—Fibroadenoma of breast—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0585	CcSEcCtD
Celecoxib—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.233	CbGbCtD
Celecoxib—PDPK1—nephron tubule—focal segmental glomerulosclerosis	0.00723	0.163	CbGeAlD
Celecoxib—PDPK1—kidney—focal segmental glomerulosclerosis	0.00635	0.143	CbGeAlD
Celecoxib—PTGS2—nephron—focal segmental glomerulosclerosis	0.00515	0.116	CbGeAlD
Celecoxib—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0223	CcSEcCtD
Celecoxib—Bullous eruption—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.0215	CcSEcCtD
Celecoxib—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.0184	CcSEcCtD
Celecoxib—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00384	0.0184	CcSEcCtD
Celecoxib—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.0173	CcSEcCtD
Celecoxib—MAPK14—kidney—focal segmental glomerulosclerosis	0.0034	0.0767	CbGeAlD
Celecoxib—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.0146	CcSEcCtD
Celecoxib—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.0146	CcSEcCtD
Celecoxib—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.0144	CcSEcCtD
Celecoxib—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.0131	CcSEcCtD
Celecoxib—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.0131	CcSEcCtD
Celecoxib—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.0125	CcSEcCtD
Celecoxib—CA12—kidney—focal segmental glomerulosclerosis	0.00258	0.0582	CbGeAlD
Celecoxib—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0119	CcSEcCtD
Celecoxib—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00243	0.0548	CbGeAlD
Celecoxib—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.0113	CcSEcCtD
Celecoxib—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0112	CcSEcCtD
Celecoxib—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.011	CcSEcCtD
Celecoxib—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.0109	CcSEcCtD
Celecoxib—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00973	CcSEcCtD
Celecoxib—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.00198	0.0446	CbGeAlD
Celecoxib—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00946	CcSEcCtD
Celecoxib—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.0094	CcSEcCtD
Celecoxib—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00934	CcSEcCtD
Celecoxib—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00934	CcSEcCtD
Celecoxib—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.00921	CcSEcCtD
Celecoxib—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00915	CcSEcCtD
Celecoxib—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00892	CcSEcCtD
Celecoxib—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00892	CcSEcCtD
Celecoxib—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00892	CcSEcCtD
Celecoxib—CA4—nephron tubule—focal segmental glomerulosclerosis	0.00182	0.041	CbGeAlD
Celecoxib—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00865	CcSEcCtD
Celecoxib—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00834	CcSEcCtD
Celecoxib—ABCC4—kidney—focal segmental glomerulosclerosis	0.00174	0.0392	CbGeAlD
Celecoxib—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00824	CcSEcCtD
Celecoxib—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.0082	CcSEcCtD
Celecoxib—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.00169	0.0382	CbGeAlD
Celecoxib—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00811	CcSEcCtD
Celecoxib—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00806	CcSEcCtD
Celecoxib—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00802	CcSEcCtD
Celecoxib—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00797	CcSEcCtD
Celecoxib—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0078	CcSEcCtD
Celecoxib—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00776	CcSEcCtD
Celecoxib—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00768	CcSEcCtD
Celecoxib—CA4—kidney—focal segmental glomerulosclerosis	0.0016	0.036	CbGeAlD
Celecoxib—CA4—cortex of kidney—focal segmental glomerulosclerosis	0.00155	0.0351	CbGeAlD
Celecoxib—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00737	CcSEcCtD
Celecoxib—CA2—nephron tubule—focal segmental glomerulosclerosis	0.00151	0.034	CbGeAlD
Celecoxib—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00709	CcSEcCtD
Celecoxib—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00705	CcSEcCtD
Celecoxib—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00695	CcSEcCtD
Celecoxib—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00689	CcSEcCtD
Celecoxib—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00686	CcSEcCtD
Celecoxib—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00683	CcSEcCtD
Celecoxib—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00659	CcSEcCtD
Celecoxib—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00656	CcSEcCtD
Celecoxib—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00653	CcSEcCtD
Celecoxib—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00645	CcSEcCtD
Celecoxib—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00637	CcSEcCtD
Celecoxib—CA2—kidney—focal segmental glomerulosclerosis	0.00132	0.0299	CbGeAlD
Celecoxib—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00631	CcSEcCtD
Celecoxib—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00631	CcSEcCtD
Celecoxib—CA2—cortex of kidney—focal segmental glomerulosclerosis	0.00129	0.0291	CbGeAlD
Celecoxib—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00616	CcSEcCtD
Celecoxib—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00607	CcSEcCtD
Celecoxib—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00577	CcSEcCtD
Celecoxib—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00565	CcSEcCtD
Celecoxib—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00563	CcSEcCtD
Celecoxib—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00557	CcSEcCtD
Celecoxib—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00545	CcSEcCtD
Celecoxib—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00533	CcSEcCtD
Celecoxib—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00524	CcSEcCtD
Celecoxib—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00522	CcSEcCtD
Celecoxib—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00519	CcSEcCtD
Celecoxib—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00512	CcSEcCtD
Celecoxib—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00498	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00495	CcSEcCtD
Celecoxib—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00492	CcSEcCtD
Celecoxib—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00485	CcSEcCtD
Celecoxib—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.001	0.0048	CcSEcCtD
Celecoxib—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000996	0.00478	CcSEcCtD
Celecoxib—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00099	0.00475	CcSEcCtD
Celecoxib—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00099	0.00475	CcSEcCtD
Celecoxib—PTGS2—kidney—focal segmental glomerulosclerosis	0.000977	0.0221	CbGeAlD
Celecoxib—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000976	0.00468	CcSEcCtD
Celecoxib—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000971	0.00466	CcSEcCtD
Celecoxib—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000971	0.00466	CcSEcCtD
Celecoxib—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.00463	CcSEcCtD
Celecoxib—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.00463	CcSEcCtD
Celecoxib—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000963	0.00462	CcSEcCtD
Celecoxib—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000963	0.00462	CcSEcCtD
Celecoxib—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000944	0.00453	CcSEcCtD
Celecoxib—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000937	0.00449	CcSEcCtD
Celecoxib—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000934	0.00448	CcSEcCtD
Celecoxib—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.00446	CcSEcCtD
Celecoxib—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000894	0.00428	CcSEcCtD
Celecoxib—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000891	0.00427	CcSEcCtD
Celecoxib—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000889	0.00426	CcSEcCtD
Celecoxib—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000889	0.00426	CcSEcCtD
Celecoxib—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000885	0.00424	CcSEcCtD
Celecoxib—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.00423	CcSEcCtD
Celecoxib—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000878	0.00421	CcSEcCtD
Celecoxib—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000874	0.00419	CcSEcCtD
Celecoxib—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000872	0.00418	CcSEcCtD
Celecoxib—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000854	0.0193	CbGeAlD
Celecoxib—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00084	0.019	CbGeAlD
Celecoxib—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.00397	CcSEcCtD
Celecoxib—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000825	0.00396	CcSEcCtD
Celecoxib—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00387	CcSEcCtD
Celecoxib—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.00384	CcSEcCtD
Celecoxib—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000794	0.00381	CcSEcCtD
Celecoxib—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.00377	CcSEcCtD
Celecoxib—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000779	0.00374	CcSEcCtD
Celecoxib—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000763	0.00366	CcSEcCtD
Celecoxib—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00076	0.00364	CcSEcCtD
Celecoxib—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00363	CcSEcCtD
Celecoxib—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000752	0.0036	CcSEcCtD
Celecoxib—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00357	CcSEcCtD
Celecoxib—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.0035	CcSEcCtD
Celecoxib—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000715	0.00343	CcSEcCtD
Celecoxib—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000707	0.00339	CcSEcCtD
Celecoxib—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000695	0.00333	CcSEcCtD
Celecoxib—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000693	0.00332	CcSEcCtD
Celecoxib—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000675	0.00324	CcSEcCtD
Celecoxib—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.0032	CcSEcCtD
Celecoxib—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00316	CcSEcCtD
Celecoxib—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00316	CcSEcCtD
Celecoxib—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00316	CcSEcCtD
Celecoxib—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.00315	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000654	0.00314	CcSEcCtD
Celecoxib—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.00309	CcSEcCtD
Celecoxib—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.00305	CcSEcCtD
Celecoxib—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000632	0.00303	CcSEcCtD
Celecoxib—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000632	0.00303	CcSEcCtD
Celecoxib—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000628	0.00301	CcSEcCtD
Celecoxib—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00297	CcSEcCtD
Celecoxib—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000619	0.00297	CcSEcCtD
Celecoxib—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00294	CcSEcCtD
Celecoxib—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000611	0.00293	CcSEcCtD
Celecoxib—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.00289	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.00276	CcSEcCtD
Celecoxib—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00274	CcSEcCtD
Celecoxib—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000567	0.00272	CcSEcCtD
Celecoxib—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.0027	CcSEcCtD
Celecoxib—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000562	0.00269	CcSEcCtD
Celecoxib—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000556	0.00267	CcSEcCtD
Celecoxib—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000549	0.00263	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00261	CcSEcCtD
Celecoxib—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00261	CcSEcCtD
Celecoxib—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00054	0.00259	CcSEcCtD
Celecoxib—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000521	0.0025	CcSEcCtD
Celecoxib—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000517	0.00248	CcSEcCtD
Celecoxib—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000502	0.00241	CcSEcCtD
Celecoxib—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00239	CcSEcCtD
Celecoxib—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.00239	CcSEcCtD
Celecoxib—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000465	0.00223	CcSEcCtD
Celecoxib—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000453	0.00217	CcSEcCtD
Celecoxib—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000447	0.00214	CcSEcCtD
Celecoxib—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000432	0.00207	CcSEcCtD
Celecoxib—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000418	0.002	CcSEcCtD
Celecoxib—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.00193	CcSEcCtD
Celecoxib—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000398	0.00191	CcSEcCtD
Celecoxib—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000398	0.00191	CcSEcCtD
Celecoxib—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.0019	CcSEcCtD
Celecoxib—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000375	0.0018	CcSEcCtD
Celecoxib—PDPK1—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000272	0.00206	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—FN1—focal segmental glomerulosclerosis	0.000269	0.00204	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000261	0.00198	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—SPP1—focal segmental glomerulosclerosis	0.000258	0.00196	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000252	0.00192	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—SPP1—focal segmental glomerulosclerosis	0.00025	0.0019	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.00025	0.00189	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000249	0.00189	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000248	0.00188	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000248	0.00188	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000245	0.00186	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—focal segmental glomerulosclerosis	0.000244	0.00185	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000238	0.0018	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Hypertrophic Response—TGFB1—focal segmental glomerulosclerosis	0.000237	0.0018	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000237	0.0018	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—FN1—focal segmental glomerulosclerosis	0.000224	0.0017	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—SERPINE1—focal segmental glomerulosclerosis	0.000224	0.0017	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000224	0.0017	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000215	0.00163	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000213	0.00162	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000206	0.00157	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000203	0.00154	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MYH9—focal segmental glomerulosclerosis	0.000201	0.00153	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000201	0.00153	CbGpPWpGaD
Celecoxib—ABCC4—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	0.000201	0.00152	CbGpPWpGaD
Celecoxib—CA14—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000196	0.00149	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000196	0.00149	CbGpPWpGaD
Celecoxib—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	0.000191	0.00145	CbGpPWpGaD
Celecoxib—CA6—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000191	0.00145	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000191	0.00145	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000187	0.00142	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000186	0.00141	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.00018	0.00136	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000178	0.00135	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000176	0.00133	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000176	0.00133	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	0.000173	0.00131	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000173	0.00131	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00017	0.00129	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000169	0.00129	CbGpPWpGaD
Celecoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—focal segmental glomerulosclerosis	0.000169	0.00128	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000169	0.00128	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000168	0.00128	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000168	0.00128	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000168	0.00127	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	0.000166	0.00126	CbGpPWpGaD
Celecoxib—CA12—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000165	0.00126	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000165	0.00125	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	0.000165	0.00125	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000164	0.00125	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	0.000164	0.00124	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000162	0.00123	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.00016	0.00121	CbGpPWpGaD
Celecoxib—CA14—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000159	0.00121	CbGpPWpGaD
Celecoxib—MAPK14—Corticotropin-releasing hormone—TGFB1—focal segmental glomerulosclerosis	0.000157	0.00119	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000157	0.00119	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000157	0.00119	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000156	0.00119	CbGpPWpGaD
Celecoxib—CA6—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000155	0.00118	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000155	0.00118	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000155	0.00117	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	0.000154	0.00117	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000154	0.00117	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000152	0.00115	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00015	0.00114	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000148	0.00113	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000147	0.00112	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000147	0.00112	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000146	0.00111	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000145	0.0011	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000145	0.0011	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	0.000144	0.00109	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000143	0.00109	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000142	0.00108	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—focal segmental glomerulosclerosis	0.000141	0.00107	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000141	0.00107	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000141	0.00107	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000141	0.00107	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	0.000137	0.00104	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000136	0.00104	CbGpPWpGaD
Celecoxib—CA12—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000134	0.00102	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000133	0.00101	CbGpPWpGaD
Celecoxib—CA4—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000132	0.001	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00013	0.000986	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	0.000129	0.000979	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000129	0.000976	CbGpPWpGaD
Celecoxib—CA2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000126	0.00096	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000125	0.000951	CbGpPWpGaD
Celecoxib—ABCC4—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000124	0.000942	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000123	0.000937	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000123	0.000936	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000122	0.00093	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000122	0.000928	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD79A—focal segmental glomerulosclerosis	0.000122	0.000926	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000121	0.000921	CbGpPWpGaD
Celecoxib—CA14—Metabolism—LPL—focal segmental glomerulosclerosis	0.00012	0.000909	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000118	0.000894	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000117	0.000886	CbGpPWpGaD
Celecoxib—CA6—Metabolism—LPL—focal segmental glomerulosclerosis	0.000117	0.000886	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000116	0.000881	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000111	0.000845	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	0.000111	0.000842	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00011	0.000836	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—LPL—focal segmental glomerulosclerosis	0.000109	0.000827	CbGpPWpGaD
Celecoxib—CA4—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000107	0.000812	CbGpPWpGaD
Celecoxib—CA9—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000107	0.000809	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MYH9—focal segmental glomerulosclerosis	0.000105	0.000795	CbGpPWpGaD
Celecoxib—CA2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000103	0.000778	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AGT—focal segmental glomerulosclerosis	0.000102	0.000777	CbGpPWpGaD
Celecoxib—CA12—Metabolism—LPL—focal segmental glomerulosclerosis	0.000101	0.000766	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000101	0.000764	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0001	0.000762	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	9.98e-05	0.000758	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AGT—focal segmental glomerulosclerosis	9.98e-05	0.000758	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AGT—focal segmental glomerulosclerosis	9.98e-05	0.000758	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	9.98e-05	0.000758	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD40LG—focal segmental glomerulosclerosis	9.95e-05	0.000755	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—LPL—focal segmental glomerulosclerosis	9.86e-05	0.000749	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	9.71e-05	0.000737	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CTGF—focal segmental glomerulosclerosis	9.38e-05	0.000712	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AGT—focal segmental glomerulosclerosis	9.32e-05	0.000707	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	9.22e-05	0.0007	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	9.14e-05	0.000694	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.14e-05	0.000693	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	9.08e-05	0.00069	CbGpPWpGaD
Celecoxib—PDPK1—Disease—LPL—focal segmental glomerulosclerosis	9.01e-05	0.000684	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	8.9e-05	0.000676	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.76e-05	0.000665	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—FN1—focal segmental glomerulosclerosis	8.74e-05	0.000663	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	8.65e-05	0.000657	CbGpPWpGaD
Celecoxib—CA9—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.64e-05	0.000656	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS2—focal segmental glomerulosclerosis	8.63e-05	0.000655	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AGT—focal segmental glomerulosclerosis	8.63e-05	0.000655	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.39e-05	0.000637	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	8.39e-05	0.000637	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	8.23e-05	0.000625	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	8.12e-05	0.000616	CbGpPWpGaD
Celecoxib—CA4—Metabolism—LPL—focal segmental glomerulosclerosis	8.05e-05	0.000611	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	7.95e-05	0.000604	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ALB—focal segmental glomerulosclerosis	7.86e-05	0.000597	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	7.79e-05	0.000592	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	7.73e-05	0.000587	CbGpPWpGaD
Celecoxib—CA2—Metabolism—LPL—focal segmental glomerulosclerosis	7.71e-05	0.000586	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.67e-05	0.000583	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	7.67e-05	0.000582	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ALB—focal segmental glomerulosclerosis	7.66e-05	0.000581	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ALB—focal segmental glomerulosclerosis	7.66e-05	0.000581	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—FN1—focal segmental glomerulosclerosis	7.65e-05	0.000581	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS2—focal segmental glomerulosclerosis	7.56e-05	0.000574	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	7.46e-05	0.000566	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—CTGF—focal segmental glomerulosclerosis	7.28e-05	0.000553	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	7.27e-05	0.000552	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—focal segmental glomerulosclerosis	7.26e-05	0.000551	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—focal segmental glomerulosclerosis	7.15e-05	0.000543	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.09e-05	0.000538	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS2—focal segmental glomerulosclerosis	7.04e-05	0.000535	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	6.88e-05	0.000523	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AGT—focal segmental glomerulosclerosis	6.88e-05	0.000523	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	6.65e-05	0.000505	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—focal segmental glomerulosclerosis	6.62e-05	0.000503	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP2—focal segmental glomerulosclerosis	6.61e-05	0.000502	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AGT—focal segmental glomerulosclerosis	6.6e-05	0.000501	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.57e-05	0.000499	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.51e-05	0.000494	CbGpPWpGaD
Celecoxib—CA9—Metabolism—LPL—focal segmental glomerulosclerosis	6.5e-05	0.000494	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	6.38e-05	0.000484	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	6.36e-05	0.000483	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—focal segmental glomerulosclerosis	6.35e-05	0.000482	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—focal segmental glomerulosclerosis	6.34e-05	0.000481	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.31e-05	0.000479	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.28e-05	0.000477	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.11e-05	0.000464	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.98e-05	0.000454	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SERPINE1—focal segmental glomerulosclerosis	5.93e-05	0.00045	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.63e-05	0.000427	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	5.6e-05	0.000425	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AGT—focal segmental glomerulosclerosis	5.56e-05	0.000422	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.4e-05	0.00041	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.38e-05	0.000408	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—focal segmental glomerulosclerosis	5.28e-05	0.000401	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.22e-05	0.000396	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.19e-05	0.000394	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40LG—focal segmental glomerulosclerosis	5.17e-05	0.000392	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—focal segmental glomerulosclerosis	5.06e-05	0.000384	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.99e-05	0.000379	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MMP9—focal segmental glomerulosclerosis	4.97e-05	0.000377	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.81e-05	0.000365	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.59e-05	0.000348	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.55e-05	0.000346	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.36e-05	0.000331	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—focal segmental glomerulosclerosis	4.27e-05	0.000324	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.15e-05	0.000315	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	4.11e-05	0.000312	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.1e-05	0.000311	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	4.03e-05	0.000306	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.02e-05	0.000305	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.99e-05	0.000303	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	3.95e-05	0.0003	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	3.91e-05	0.000297	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.9e-05	0.000296	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—focal segmental glomerulosclerosis	3.74e-05	0.000284	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.73e-05	0.000283	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.69e-05	0.00028	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.62e-05	0.000274	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.38e-05	0.000257	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.33e-05	0.000253	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	3.32e-05	0.000252	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	3.32e-05	0.000252	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	3.29e-05	0.00025	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.28e-05	0.000249	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.19e-05	0.000242	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.18e-05	0.000241	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.11e-05	0.000236	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	2.99e-05	0.000227	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	2.93e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.81e-05	0.000213	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.74e-05	0.000208	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.72e-05	0.000206	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.7e-05	0.000205	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.62e-05	0.000199	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.59e-05	0.000197	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	2.51e-05	0.00019	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.45e-05	0.000186	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.42e-05	0.000183	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.39e-05	0.000182	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	2.34e-05	0.000177	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.23e-05	0.000169	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.21e-05	0.000167	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.16e-05	0.000164	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	2.14e-05	0.000163	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.08e-05	0.000158	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	2.03e-05	0.000154	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	1.97e-05	0.000149	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.79e-05	0.000136	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	1.73e-05	0.000132	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.67e-05	0.000127	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.66e-05	0.000126	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.65e-05	0.000125	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	1.65e-05	0.000125	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.58e-05	0.00012	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.45e-05	0.00011	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.43e-05	0.000109	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.42e-05	0.000108	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.36e-05	0.000103	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	1.24e-05	9.43e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.1e-05	8.34e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.09e-05	8.31e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.09e-05	8.27e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	9.36e-06	7.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	7.19e-06	5.46e-05	CbGpPWpGaD
